Amide prodrug of gemcitabine, compositions and use thereof

Details for Australian Patent Application No. 2005316922 (hide)

Owner Eli Lilly and Company

Inventors Bender, David Michael; Remick, David Michael

Agent Spruson & Ferguson

Pub. Number AU-B-2005316922

PCT Pub. Number WO2006/065525

Priority 60/637,422 17.12.04 US

Filing date 30 November 2005

Wipo publication date 22 June 2006

Acceptance publication date 25 August 2011

International Classifications

C07H 19/073 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

24 May 2007 PCT application entered the National Phase

  PCT publication WO2006/065525 Priority application(s): WO2006/065525

25 August 2011 Application Accepted

  Published as AU-B-2005316922

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005316930-Methods and compositions for a microemulsion-based tissue treatment

2005316919-Oral compositions containing extracts of Rosmarinus and related methods